Equity
CVS Health·Balance Sheet Statement·10 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $252.5B | $252.4B | $253.2B | $255.6B | $258.3B | $255.3B | $253.5B | $253B |
| Total stockholders' equity | $74.9B | $74.9B | $75.6B | $76.9B | $77.4B | $72.9B | $75.2B | $77.5B |
| Retained earnings | $62.8B | $62B | $62.8B | $63.8B | $63.9B | $59.1B | $61.2B | $63.3B |
| Common stock | $49.4B | $49.5B | $49.7B | $49.8B | $50B | $50.2B | $50.4B | $50.7B |
| Treasury stock | $36.9B | $36.8B | $36.8B | $36.7B | $36.8B | $36.8B | $36.8B | $36.7B |
| Investments - Gross Unrealized Losses | $15B | $7.5B | $13.2B | $9.9B | $6.6B | $5.4B | $6.3B | $12.8B |
| AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss | $799M | $446M | $580M | $476M | $396M | $307M | $301M | $305M |
| Accumulated other comprehensive income (loss) | -$319M | $209M | -$120M | $59M | $272M | $416M | $406M | $201M |
| AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss | 3497.00 | 493.00 | 4502.00 | 3012.00 | 1528.00 | 1110.00 | 1578.00 | 5268.00 |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |